semaglutide and tirzepatide weight loss vs for Tirzepatide GLP-1 medication may be

The body already runs on peptides, using these short amino-acid chains to direct repair, metabolism, and other functions

3 This is due in part to the higher morbidity associated with obesity in hypertension, type 2 diabetes, coronary heart disease, stroke, gall-bladder disease, osteoarthritis, sleep apnea, and some types of cancer (endometrial, breast, prostate, and colon)

Neurochemical Research 22, 727-733CrossRefGoogle ScholarPubMed 113Dringen, R., Gutterer, J.M., Gros, C

Daytime impairment from sleep deprivation that affects work performance, driving safety, or daily functioning should not be tolerated as a medication side effect

Treatment with oral semaglutide resulted in a mean A1C reduction from baseline of -1.3% at week 52 for both estimand calculations